EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Silico Assessment of Potential Geroprotectors: From Separate Endpoints to Complex Pharmacotherapeutic Effects

Leonid Stolbov iD, Anastasia Rudik iD, Alexey Lagunin iD, Dmitry Druzhilovskiy iD, Dmitry Filimonov iD, Vladimir Poroikov iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26188858 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Leonid Stolbov und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Chemistry, 10 Bldg. 8, Pogodinskaya Str., 119121 Moscow, Russia. Hauptthemen laut MEDLINE: Computer Simulation, Aging. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study presents an approach for the in silico assessment of potential geroprotectors that target the multifaceted mechanisms of aging, implemented in the PASS GERO web application. This work is timely given the societal impact of aging—the primary risk factor for major chronic diseases. The urgent need to extend healthspan—the period of life spent in good health—motivates the search for compounds that modulate fundamental aging mechanisms. The model estimates the probabilities of 117 aging-related biological activities with high predictive accuracy, achieving an average Invariant Accuracy of Prediction (IAP) of 0.967 under cross-validation. Validation using known geroprotectors (rapamycin, metformin, and resveratrol) demonstrated strong concordance between predicted activities and documented molecular mechanisms of action. For instance, the model correctly predicted rapamycin’s inhibition of mTOR and metformin’s activation of AMPK. The PASS GERO web application provides a systematic strategy to prioritize novel compound candidates for experimental evaluation in anti-aging research. We discuss challenges including the chemical diversity of the training data, the need for validated biomarkers, and the limitations of translating computational predictions into clinical outcomes, positioning the tool as robust application for activity profiling in discovery workflows.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Computer SimulationAgingHumansMetforminSirolimusResveratrol

Stichwörter der Autor:innen

PASS GEROaginggeroprotectorsin silico assessmentstructure-activity relationships

Substanzen

MetforminSirolimusResveratrol

Autor:innen und Institutionen

  • Institute of Biomedical Chemistry, 10 Bldg. 8, Pogodinskaya Str., 119121 Moscow, Russia.
  • Bioinformatics Department, Pirogov Russian National Research Medical University, 1 Bldg. 6 Ostrovityanova Str., 117513 Moscow, Russia.

ORCID-Profile: Leonid Stolbov, Anastasia Rudik, Alexey Lagunin, Dmitry Druzhilovskiy, Dmitry Filimonov, Vladimir Poroikov

Förderung

  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Stolbov, L., Rudik, A., Lagunin, A., Druzhilovskiy, D., Filimonov, D., & Poroikov, V. (2025). In Silico Assessment of Potential Geroprotectors: From Separate Endpoints to Complex Pharmacotherapeutic Effects. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26188858

Vancouver

Stolbov L, Rudik A, Lagunin A, Druzhilovskiy D, Filimonov D, Poroikov V. In Silico Assessment of Potential Geroprotectors: From Separate Endpoints to Complex Pharmacotherapeutic Effects. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26188858

BibTeX
@article{Stolbov2025,
  author = {Stolbov, Leonid and Rudik, Anastasia and Lagunin, Alexey and Druzhilovskiy, Dmitry and Filimonov, Dmitry and Poroikov, Vladimir},
  title = {In Silico Assessment of Potential Geroprotectors: From Separate Endpoints to Complex Pharmacotherapeutic Effects},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26188858}
}
Kostenlos starten →